// App-Quantinova.ai

2223 : Analytical validation of a novel circulating tumor cell platform (CMx) for early detection of cancer

Researchers

Presenter

  • Hung-Jen Shao

Principal Investigators

  • Huangpin B. Hsieh

  • Wen-Sy Tsai

  • Jen-chia Wu

  • Jr-Ming Lai

  • Shih-En Chang

  • Mana Javey

  • Oscar Segurado

  • Mahul B. Amin

  • Ashish Nimgaonkar

  • Rui Mei

Medical Centers

  • CellMax Life, Sunnyvale, CA

  • Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

  • Medic Affairs Consulting LLC, San Jose, CA

  • The University of Tennessee Health Science Center, Memphis, TN

  • The Johns Hopkins Hospital, Baltimore, MD

Locations

  • United States

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Cytokeratin 20

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved